Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price and Market Data

Takeda Pharmaceutical Company Limited is Japan’s largest pharmaceutical company, generating JPY 4.6 trillion in revenue in fiscal 2024. The company focuses on five core therapeutic areas—oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies—which together contribute more than 80% of total revenue. Takeda also maintains a well-diversified geographic presence, with more than 50% of revenue coming from the United States, 20% from Japan, and 20% from Europe and Canada.